Actionable Pharmacogenetic Variation in the Slovenian Genomic Database
Background: Genetic variability in some of the genes that affect absorption, distribution, metabolism, and elimination (“pharmacogenes”) can significantly influence an individual’s response to the drug and consequently the effectiveness of treatment and possible adverse drug events. The rapid develo...
Main Authors: | Keli Hočevar, Aleš Maver, Borut Peterlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00240/full |
Similar Items
-
The Pharmacogenetics of Treatment with Quetiapine
by: María Ortega-Ruiz, et al.
Published: (2022-07-01) -
Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data
by: Luciana Bertholim-Nasciben, et al.
Published: (2023-05-01) -
Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB
by: Mohammad A. Alshabeeb, et al.
Published: (2022-10-01) -
Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
by: Michael J. Schuh, et al.
Published: (2020-05-01) -
Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
by: Heibein Allan D, et al.
Published: (2012-08-01)